Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reproductive endocrinology

H S Jacobs1

  • 1The Middlesex Hospital, Mortimer Street, London.

Current Opinion in Obstetrics & Gynecology
|August 29, 1998
PubMed
Summary
This summary is machine-generated.

This issue reviews the safety of reproductive medicine treatments. It covers established medications like oral contraceptives and ovulation induction drugs, alongside new therapies for polycystic ovary syndrome and osteoporosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Idiopathic gonadotrophin deficiency: genetic questions addressed through phenotypic characterization.

Clinical endocrinology·2001
Same author

Postmenopausal hormone replacement therapy and breast cancer.

Medscape women's health·2000
Same author

Effects of laparoscopic ovarian drilling on serum vascular endothelial growth factor and on insulin responses to the oral glucose tolerance test in women with polycystic ovary syndrome.

Fertility and sterility·2000
Same author

Hormone replacement therapy and breast cancer.

Endocrine-related cancer·2000
Same author

For and against: The male menopause--does it exist?

BMJ (Clinical research ed.)·2000
Same author

Follicle-stimulating hormone or human menopausal gonadotropin for ovarian stimulation in in vitro fertilization cycles: a meta-analysis.

Fertility and sterility·2000
Same journal

Management of hypertensive disorders in pregnancy.

Current opinion in obstetrics & gynecology·2026
Same journal

Updates in group prenatal care research.

Current opinion in obstetrics & gynecology·2026
Same journal

Complex benign gynecology in perimenopause: current evidence and future directions.

Current opinion in obstetrics & gynecology·2026
Same journal

Role of insulin in female reproduction.

Current opinion in obstetrics & gynecology·2026
Same journal

Urinary tract involvement in endometriosis: current evidence and clinical insights into navigating diagnosis and management.

Current opinion in obstetrics & gynecology·2026
Same journal

Updates in ultrasound imaging of adenomyosis and clinical impacts.

Current opinion in obstetrics & gynecology·2026
See all related articles

Area of Science:

  • Reproductive Medicine
  • Endocrinology
  • Pharmacology

Background:

  • This issue addresses the critical aspect of medical treatment safety in reproductive medicine.
  • It examines both established and novel therapeutic approaches.

Discussion:

  • Focuses on the safety profiles of oral contraceptive pills and ovulation induction drugs.
  • Evaluates the benefits and risks of new treatments, including insulin reduction for polycystic ovary syndrome (PCOS) and selective estrogen receptor modulators (SERMs) for postmenopausal osteoporosis.

Key Insights:

  • Established treatments like oral contraceptives and ovulation induction drugs are reviewed for their safety.
  • Emerging therapies for PCOS and osteoporosis present unique safety considerations.
  • The integration of new pharmacological agents requires careful risk-benefit assessment.

Related Experiment Videos

Outlook:

  • Continued research into the long-term safety of reproductive treatments is essential.
  • Personalized medicine approaches may optimize treatment safety and efficacy.
  • Future developments will likely focus on enhancing safety profiles of existing and novel therapies.